Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Mapping Infarct Structure to Cardiac Electrophysiology
2026-11-04
A proof-of-concept study combined panoramic hyperspectral imaging with optical mapping to relate epicardial tissue composition to cardiac electrical activity in infarcted rat hearts. The approach showed feasibility for spatially paired structure–function analysis while remaining limited by its small ex vivo model, epicardial-only view, motion suppression, and preliminary electrophysiological associations.
Anti-CLEC7A Antibody: What Does It Show?
2026-11-04
A CLEC7A antibody signal can represent receptor recognition, accessible Dectin-1, molecular binding, or a downstream cellular response. This article separates those evidence levels and explains what the documented properties of a humanized IgG4 antibody can—and cannot—establish.
What Does ER-Tracker Green Fluorescence Measure?
2026-11-03
ER-Tracker Green is a BODIPY FL labeled glibenclamide probe whose live-cell fluorescence is linked to sulfonylurea receptor-associated sites, not a direct measurement of endoplasmic reticulum abundance or function. Its documented mechanism supports a localization readout, while receptor variability, possible ER perturbation, fixation-related signal loss, and the absence of independent quantitative validation limit broader conclusions.
CMC Translation of mRNA Lipid Nanoparticles
2026-11-03
A review-centred interpretation of how lipid chemistry, carrier choice, manufacturing strategy, analytical characterization, stability assessment, and comparability planning shape the translation of mRNA delivery systems.
CMC Translation of mRNA Lipid Nanoparticles
2026-11-02
A paper-centred interpretation of how lipid chemistry, carrier selection, manufacturing control, analytical characterization, stability assessment, and comparability planning shape the translation of mRNA delivery systems.
How H4 Receptor Antagonism Shapes Inflammation Signals
2026-11-02
JNJ-7777120 is described as a selective histamine H4 receptor antagonist. Its reported binding, selectivity, inflammatory readouts, and species-dependent pharmacokinetic properties help explain how a molecular interaction may connect to immune-cell behavior, while also defining the limits of the evidence.
Nanopore Electroporation and saRNA Delivery
2026-11-01
A paper examines whether localized nanopore electroporation can deliver large self-amplifying RNA to dendritic cells while preserving viability. Its results support device-level feasibility in a defined in vitro model, while leaving questions about primary cells, immune function, cargo integrity and translational performance.
U1 Promoters Redirect Cytosolic Cas13 Guides
2026-10-31
A cell-based study found that replacing the conventional U6 promoter with U1 shifted CRISPR-Cas13 guide RNAs toward the cytosol and improved several RNA-targeting activities. The results point to guide localization and transcript-end processing as mechanistic determinants, while remaining bounded by the tested cell models, effectors, and guide architectures.
Interpreting α-Mangostin Cancer Pathway Readouts
2026-10-30
α-Mangostin is associated with distinct PI3K/Akt and fatty acid synthase readouts in pancreatic and breast cancer models. Interpreting these findings requires separating molecular signaling changes from cell-state transitions, apoptosis markers, and xenograft growth, while recognizing that the evidence remains model-specific and preclinical.
How CLBRP Coordinates Tumor Killing and Immunity
2026-10-30
A preclinical study examined a calcium lactate nanoparticle system that co-delivers bufalin with CRISPR/Cas9 components targeting CD47. The reported results connect tumor-cell stress, pyroptosis-associated signaling, immunogenic cell-death markers, macrophage repolarization, phagocytosis, and tumor localization in murine colorectal-cancer models, while leaving human translation and editing specificity unresolved.
How Eribulin Mesylate Disrupts Cell Division
2026-10-29
Eribulin mesylate is best interpreted through a causal chain: interaction with tubulin alters microtubule dynamics, spindle function becomes impaired, cell-cycle checkpoints are engaged, and later measurements may show cell death. Each readout supports a different level of inference, so microtubule disruption, cell-cycle arrest, and apoptosis should not be treated as interchangeable evidence.
How to Interpret Ro60-0175 Receptor Readouts
2026-10-29
A receptor agonist finding can support molecular and signaling conclusions without proving a behavioral effect. This article explains how to interpret Ro60-0175 across binding assays, receptor signaling, cellular responses, and addiction mechanism research while keeping product documentation distinct from independent validation.
How L-Ornithine L-aspartate Informs Nitrogen Studies
2026-10-28
L-Ornithine L-aspartate is best interpreted as a defined ornithine–aspartate compound whose relevance comes from nitrogen metabolism. Its biochemical rationale connects to the hepatic urea cycle, but ammonia, urea, and glutamine measure different layers of pathway behavior and cannot be treated as interchangeable evidence.
How Should Isotretinoin Readouts Be Interpreted?
2026-10-27
Isotretinoin, also called 13-cis-retinoic acid, produces findings at several biological levels, from sebocyte proliferation and lipid synthesis to keratin expression and graft inflammation. These readouts can be biologically related without proving one unified mechanism, so their interpretation depends on separating cellular effects, molecular correlates, and tissue-level outcomes.
What PET Reveals About mRNA Antigen Expression
2026-10-27
A PET reporter strategy offers a way to observe where and when an mRNA-encoded antigen is translated, rather than tracking only the delivery vehicle or nucleic acid. The reported mouse and non-human-primate findings support a proof-of-concept interpretation, while leaving important questions about quantitative calibration, antigen function, formulation effects and translation to human studies unresolved.